TR201903899T4 - Demir eksikliği durumlarında kullanıma yönelik demir içeren katı bileşim. - Google Patents

Demir eksikliği durumlarında kullanıma yönelik demir içeren katı bileşim. Download PDF

Info

Publication number
TR201903899T4
TR201903899T4 TR2019/03899T TR201903899T TR201903899T4 TR 201903899 T4 TR201903899 T4 TR 201903899T4 TR 2019/03899 T TR2019/03899 T TR 2019/03899T TR 201903899 T TR201903899 T TR 201903899T TR 201903899 T4 TR201903899 T4 TR 201903899T4
Authority
TR
Turkey
Prior art keywords
iron
solid composition
present
containing solid
iron deficiency
Prior art date
Application number
TR2019/03899T
Other languages
English (en)
Inventor
Lacorte Andrea
Tarantino Germano
Original Assignee
Alesco S R L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alesco S R L filed Critical Alesco S R L
Publication of TR201903899T4 publication Critical patent/TR201903899T4/tr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/26Iron; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/42Phosphorus; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1617Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1617Organic compounds, e.g. phospholipids, fats
    • A61K9/1623Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1652Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
  • Obesity (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pretreatment Of Seeds And Plants (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)

Abstract

Mevcut buluş, toplam veya göreceli demir eksikliği durumlarında kullanıma yönelik bir demir bazlı bileşim ile ilgilidir. Özellikle, mevcut buluş, demir eksikliği ile ilgili veya bu eksiklikten türetilen bozuklukların veya hastalıkların tedavisinde kullanıma yönelik tercihen toz veya granül formunda bir katı bileşim ile ilgilidir. Mevcut buluşun bileşimi, pediyatrik sujeler, ergenler, atletler, erkekler, kadınlar, hamile kadın ve yaşlı insanlar için uygundur. Son olarak, mevcut buluş, söz konusu katı bileşimin hazırlanmasına yönelik bir proses ile ilgilidir.
TR2019/03899T 2012-07-31 2013-07-30 Demir eksikliği durumlarında kullanıma yönelik demir içeren katı bileşim. TR201903899T4 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT001350A ITMI20121350A1 (it) 2012-07-31 2012-07-31 Composizione solido a base di ferro per uso nelle condizioni di deficienza di ferro.

Publications (1)

Publication Number Publication Date
TR201903899T4 true TR201903899T4 (tr) 2019-04-22

Family

ID=46982695

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2019/03899T TR201903899T4 (tr) 2012-07-31 2013-07-30 Demir eksikliği durumlarında kullanıma yönelik demir içeren katı bileşim.

Country Status (24)

Country Link
US (2) US10183077B2 (tr)
EP (2) EP3498265B1 (tr)
JP (1) JP6232426B2 (tr)
CN (2) CN111265546A (tr)
BR (2) BR122022015143B1 (tr)
CA (1) CA2879681C (tr)
CY (2) CY1121435T1 (tr)
DK (2) DK3498265T3 (tr)
EA (1) EA027684B1 (tr)
ES (2) ES2719252T3 (tr)
HR (2) HRP20190461T1 (tr)
HU (2) HUE052036T2 (tr)
IL (2) IL236793A0 (tr)
IN (1) IN2015MN00127A (tr)
IT (1) ITMI20121350A1 (tr)
LT (2) LT3498265T (tr)
MA (1) MA20150375A1 (tr)
ME (1) ME03349B (tr)
PL (2) PL3498265T3 (tr)
PT (2) PT3498265T (tr)
RS (2) RS58647B1 (tr)
SI (2) SI3498265T1 (tr)
TR (1) TR201903899T4 (tr)
WO (1) WO2014009806A1 (tr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20121350A1 (it) 2012-07-31 2014-02-01 Alesco Srl Composizione solido a base di ferro per uso nelle condizioni di deficienza di ferro.
ITMI20131483A1 (it) * 2013-09-09 2015-03-10 Alesco Srl Composizioni in forma solida a base di minerali e formulazioni orosolubili contenenti le stesse.
JP6299689B2 (ja) * 2014-07-24 2018-03-28 三生医薬株式会社 生体吸収促進剤含有組成物
JP6459129B2 (ja) * 2015-04-13 2019-01-30 富田製薬株式会社 ピロリン酸第二鉄含有粉末及びその製造方法
WO2017090198A1 (ja) * 2015-11-27 2017-06-01 太陽化学株式会社 鉄含有粉末組成物
IT201700085412A1 (it) * 2017-07-26 2019-01-26 Pharmanutra S P A Composizione per uso nella prevenzione e nel trattamento di patologie dell'apparato cardiovascolare
IT201700089258A1 (it) * 2017-08-02 2019-02-02 Pharmanutra S P A Composizione per uso nella prevenzione e nel trattamento di carenza di ferro
IT201800006288A1 (it) * 2018-06-13 2019-12-13 Composizioni comprendenti minerali sucrosomiali contenenti sali minerali per uso nelle condizioni di deficienza di tali minerali
IT201900020300A1 (it) 2019-11-04 2021-05-04 Alesco Srl Uso di berberina sucrosomiale® e sue composizioni nel trattamento di dislipidemie
IT201900020316A1 (it) 2019-11-04 2021-05-04 Alesco Srl Uso di berberina sucrosomiale® e sue composizioni nel trattamento di alterazioni del metabolismo glucidico
IT201900020290A1 (it) 2019-11-04 2021-05-04 Alesco Srl Berberina sucrosomiale®, sue composizioni e loro uso
IT201900021564A1 (it) * 2019-11-19 2021-05-19 Neilos S R L Composizione nutraceutica o farmaceutica comprendente ferro pirofosfato per l’uso nel trattamento e/o nella prevenzione di condizioni o patologie caratterizzate da carenza di ferro
IT201900023016A1 (it) 2019-12-04 2021-06-04 Alesco Srl Formulazioni comprendenti un minerale e un polisaccaride, loro composizioni e loro uso nella supplementazione di detto minerale
IT201900022989A1 (it) 2019-12-04 2021-06-04 Alesco Srl Formulazione in forma solida di cromo, sue composizioni e usi
WO2022118274A1 (en) * 2020-12-03 2022-06-09 Neilos S.r.l. Compositions for the use in the treatment and/or prevention of iron deficiency conditions or diseases
IT202100005981A1 (it) 2021-03-12 2022-09-12 Pharmanutra S P A Composizione a base di ferro per uso in un trattamento di una infiammazione gastrointestinale in soggetti sottoposti ad un trattamento di una deficienza di ferro
IT202100011084A1 (it) 2021-04-30 2022-10-30 Pharmanutra S P A Composizione nutraceutica per uso nel trattamento della stanchezza cronica/fatigue post covid-19
WO2023033750A1 (en) * 2021-08-30 2023-03-09 Ilko Ilac Sanayi Ve Ticaret A.S. Preservative free liquid formulation of lipozomal iron

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0927025A4 (en) * 1996-09-18 2001-07-25 Dragoco Inc DRY POWDER COMPOSITION WITH ACTIVE INGREDIENT ENCLOSED IN LIPOSOMES
US6074675A (en) 1996-10-03 2000-06-13 Taiyo Kagaku Co., Ltd. Mineral composition
JP2000300213A (ja) * 1999-04-21 2000-10-31 Taiyo Kagaku Co Ltd ミネラル組成物及びミネラル強化飲食品
US6521247B1 (en) * 1999-08-13 2003-02-18 Warner Chilcott Laboratories Ireland Limited Dual iron containing nutritional supplement
JP2007224054A (ja) * 2004-02-02 2007-09-06 Taiyo Kagaku Co Ltd 鉄組成物
JP4627999B2 (ja) * 2004-02-27 2011-02-09 太陽化学株式会社 坑酸化剤
WO2005082167A1 (en) * 2004-02-27 2005-09-09 Taiyo Kagaku Co., Ltd. Minera-containing composition and method of use thereof
JP2006340612A (ja) * 2005-06-07 2006-12-21 Taiyo Kagaku Co Ltd ミネラル強化用組成物
JP2006340613A (ja) * 2005-06-07 2006-12-21 Taiyo Kagaku Co Ltd 鉄強化用組成物
JP4738410B2 (ja) * 2005-06-22 2011-08-03 太陽化学株式会社 鉄強化用組成物
CA2634751C (en) * 2005-12-23 2017-10-31 Ajay Gupta Parenteral nutrition composition containing iron
JP4673235B2 (ja) * 2006-02-16 2011-04-20 太陽化学株式会社 鉄強化食品用組成物
CA2664406A1 (en) * 2006-09-28 2008-04-03 Bayer Consumer Care Ag Mixture of iron and copper salts masking metallic taste
CA2802184C (en) * 2010-06-09 2019-01-08 Emisphere Technologies, Inc. Oral iron deficiency therapy
US20120288531A1 (en) * 2011-01-14 2012-11-15 Shmuel Tuvia pharmaceutical compositions for delivery of ferric iron compounds, and methods of use thereof
ITMI20121350A1 (it) 2012-07-31 2014-02-01 Alesco Srl Composizione solido a base di ferro per uso nelle condizioni di deficienza di ferro.
US9594814B2 (en) 2012-09-07 2017-03-14 Splunk Inc. Advanced field extractor with modification of an extracted field

Also Published As

Publication number Publication date
HRP20201802T1 (hr) 2021-03-19
US20190105393A1 (en) 2019-04-11
US20150250885A1 (en) 2015-09-10
ITMI20121350A1 (it) 2014-02-01
HUE052036T2 (hu) 2021-04-28
EP3498265B1 (en) 2020-09-30
EA027684B1 (ru) 2017-08-31
CN111265546A (zh) 2020-06-12
CY1123610T1 (el) 2022-03-24
DK2879667T3 (en) 2019-04-15
BR112015002072B1 (pt) 2022-11-01
CY1121435T1 (el) 2020-05-29
IL265561B (en) 2021-02-28
PT3498265T (pt) 2020-11-16
EP3498265A1 (en) 2019-06-19
RS61069B1 (sr) 2020-12-31
IL236793A0 (en) 2015-03-31
LT3498265T (lt) 2021-01-25
EA201590204A1 (ru) 2015-06-30
SI3498265T1 (sl) 2021-02-26
ME03349B (me) 2019-10-20
ES2830428T3 (es) 2021-06-03
PL3498265T3 (pl) 2021-03-08
HUE042698T2 (hu) 2019-07-29
ES2719252T3 (es) 2019-07-09
EP2879667A1 (en) 2015-06-10
US10183077B2 (en) 2019-01-22
BR112015002072A2 (pt) 2017-07-04
DK3498265T3 (da) 2020-11-16
MA20150375A1 (fr) 2015-10-30
PT2879667T (pt) 2019-04-15
CN104602674A (zh) 2015-05-06
WO2014009806A1 (en) 2014-01-16
JP6232426B2 (ja) 2017-11-15
PL2879667T3 (pl) 2019-07-31
SI2879667T1 (sl) 2019-07-31
CA2879681A1 (en) 2014-01-16
BR122022015143B1 (pt) 2023-05-09
LT2879667T (lt) 2019-05-10
US10765752B2 (en) 2020-09-08
CA2879681C (en) 2022-06-21
IL265561A (en) 2019-05-30
EP2879667B1 (en) 2019-01-16
HRP20190461T1 (hr) 2019-06-14
IN2015MN00127A (tr) 2015-10-16
RS58647B1 (sr) 2019-05-31
JP2015523409A (ja) 2015-08-13

Similar Documents

Publication Publication Date Title
TR201903899T4 (tr) Demir eksikliği durumlarında kullanıma yönelik demir içeren katı bileşim.
WO2015031808A3 (en) Diagnostic methods and compositions for treatment of glioblastoma
IN2015DN02826A (tr)
IN2014DN08761A (tr)
MX356802B (es) Marcadores biologicos para identificar pacientes para tratamiento con antagonistas de vegf.
MX2015002289A (es) Anticuerpos humanos para gfr alfa 3 y métodos para su uso.
PH12014502577A1 (en) Compositions comprising an anti-pdgf aptamer and a vegf antagonist
MY165086A (en) Formulations of rifaximin and uses thereof
MX2014008706A (es) Compuestos tricíclicos de sulfonamida y métodos para elaborarlos y usarlos.
GB201109238D0 (en) Antibodies
PH12015500610B1 (en) Oral care composition
MX2015005732A (es) Compuestos tricíclicos y métodos para hacer y utilizar los mismos.
MX336204B (es) Una composicion y uso de la misma en el tratamiento de ragades anales.
NZ631639A (en) Methods and compositions for treating and diagnosing acute myocardial infarction
IN2014DN09437A (tr)
EA201290740A1 (ru) Колготки с асимметричной торсовой частью
NZ596218A (en) Bssl antagonists for treatment of inflammatory diseases
MX2015009549A (es) Composicion para el cuidado de la piel.
AU344178S (en) Women's fashion clothing
AU344179S (en) Women's fashion clothing
AU344180S (en) Women's fashion clothing
AU344181S (en) Women's fashion clothing
AU344177S (en) Women's fashion clothing
AU344182S (en) Women's fashion clothing
AU344185S (en) Women's fashion clothing